Acrivon Therapeutics, Common Stock Technical Analysis
| ACRV Stock | 7.52 0.17 2.31% |
As of the 28th of November, Acrivon Therapeutics, shows the Risk Adjusted Performance of (0.03), standard deviation of 4.21, and Mean Deviation of 2.87. Acrivon Therapeutics, technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Acrivon Therapeutics, information ratio and kurtosis to decide if Acrivon Therapeutics, is priced correctly, providing market reflects its regular price of 7.52 per share. Given that Acrivon Therapeutics, has information ratio of (0.08), we suggest you to validate Acrivon Therapeutics, Common's prevailing market performance to make sure the company can sustain itself at a future point.
Acrivon Therapeutics, Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Acrivon, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AcrivonAcrivon |
Acrivon Therapeutics, Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 23.13 | Strong Buy | 10 | Odds |
Most Acrivon analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Acrivon stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Acrivon Therapeutics,, talking to its executives and customers, or listening to Acrivon conference calls.
Acrivon Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Acrivon Therapeutics, Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Acrivon Therapeutics, volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Acrivon Therapeutics, Trend Analysis
Use this graph to draw trend lines for Acrivon Therapeutics, Common. You can use it to identify possible trend reversals for Acrivon Therapeutics, as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Acrivon Therapeutics, price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Acrivon Therapeutics, Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Acrivon Therapeutics, Common applied against its price change over selected period. The best fit line has a slop of 0.0091 , which may suggest that Acrivon Therapeutics, Common market price will keep on failing further. It has 122 observation points and a regression sum of squares at 3.14, which is the sum of squared deviations for the predicted Acrivon Therapeutics, price change compared to its average price change.About Acrivon Therapeutics, Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Acrivon Therapeutics, Common on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Acrivon Therapeutics, Common based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Acrivon Therapeutics, price pattern first instead of the macroeconomic environment surrounding Acrivon Therapeutics,. By analyzing Acrivon Therapeutics,'s financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Acrivon Therapeutics,'s intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Acrivon Therapeutics, specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 34.46 | 19.61 | 9.75 | 13.32 | Net Debt To EBITDA | 6.1 | 0.82 | 0.52 | 0.5 |
Acrivon Therapeutics, November 28, 2024 Technical Indicators
Most technical analysis of Acrivon help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Acrivon from various momentum indicators to cycle indicators. When you analyze Acrivon charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.12) | |||
| Mean Deviation | 2.87 | |||
| Coefficient Of Variation | (1,974) | |||
| Standard Deviation | 4.21 | |||
| Variance | 17.74 | |||
| Information Ratio | (0.08) | |||
| Jensen Alpha | (0.43) | |||
| Total Risk Alpha | (0.86) | |||
| Treynor Ratio | (0.13) | |||
| Maximum Drawdown | 22.84 | |||
| Value At Risk | (7.65) | |||
| Potential Upside | 7.66 | |||
| Skewness | (0.23) | |||
| Kurtosis | 1.64 |
Additional Tools for Acrivon Stock Analysis
When running Acrivon Therapeutics,'s price analysis, check to measure Acrivon Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acrivon Therapeutics, is operating at the current time. Most of Acrivon Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Acrivon Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acrivon Therapeutics,'s price. Additionally, you may evaluate how the addition of Acrivon Therapeutics, to your portfolios can decrease your overall portfolio volatility.